A Novel Ras Antagonist Regulates Both Oncogenic Ras and the Tumor Suppressor p53 in Colon Cancer Cells

被引：0
|
作者：
Julius Halaschek-Wiener
Volker Wacheck
Hermine Schlagbauer-Wadl
Klaus Wolff
Yoel Kloog
Burkhard Jansen
机构：
[1] Section of Experimental Oncology/Molecular Pharmacology,Department of Clinical Pharmacology
[2] Division of General Dermatology,Department of Dermatology
[3] Tel Aviv University,Department of Neurobiochemistry, The George S. Wise Faculty of Life Sciences
来源：
Molecular Medicine | 2000年 / 6卷
关键词：
Colon Cancer Cells; FTS Treatment; Trans-farnesylthiosalicylic Acid; Treatment-resistant Malignancies; Cyclin Cyclin-dependent Kinases (CDK);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：693 / 704
页数：11
相关论文
共 50 条
  • [21] Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53
    Malkomes, Patrizia
    Lunger, Ilaria
    Oppermann, Elsie
    Abou-El-Ardat, Khalil
    Oellerich, Thomas
    Guenther, Stefan
    Canbulat, Can
    Bothur, Sabrina
    Schnuetgen, Frank
    Yu, Weijia
    Wingert, Susanne
    Haetscher, Nadine
    Catapano, Claudia
    Dietz, Marina S.
    Heilemann, Mike
    Kvasnicka, Hans-Michael
    Holzer, Katharina
    Serve, Hubert
    Bechstein, Wolf Otto
    Rieger, Michael A.
    ONCOGENE, 2021, 40 (25) : 4352 - 4367
  • [22] Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer
    Escobar-Hoyos, Luisa F.
    Penson, Alex
    Kannan, Ram
    Cho, Hana
    Pan, Chun-Hao
    Singh, Rohit K.
    Apken, Lisa H.
    Hobbs, G. Aaron
    Luo, Renhe
    Lecomte, Nicolas
    Babu, Sruthi
    Pan, Fong Cheng
    Alonso-Curbelo, Direna
    Morris, John P.
    Askan, Gokce
    Grbovic-Huezo, Olivera
    Ogrodowski, Paul
    Bermeo, Jonathan
    Saglimbeni, Joseph
    Cruz, Cristian D.
    Ho, Yu-Jui
    Lawrence, Sharon A.
    Melchor, Jerry P.
    Goda, Grant A.
    Bai, Karen
    Pastore, Alessandro
    Hogg, Simon J.
    Raghavan, Srivatsan
    Bailey, Peter
    Chang, David K.
    Biankin, Andrew
    Shroyer, Kenneth R.
    Wolpin, Brian M.
    Aguirre, Andrew J.
    Ventura, Andrea
    Taylor, Barry
    Der, Channing J.
    Dominguez, Daniel
    Kummel, Daniel
    Oeckinghaus, Andrea
    Lowe, Scott W.
    Bradley, Robert K.
    Abdel-Wahab, Omar
    Leach, Steven D.
    CANCER CELL, 2020, 38 (02) : 198 - +
  • [23] ras and p53 genes in male breast cancer
    Dawson, PJ
    Schroer, KR
    Wolman, SR
    MODERN PATHOLOGY, 1996, 9 (04) : 367 - 370
  • [24] RUNX3 and p53: How Two Tumor Suppressors Cooperate Against Oncogenic Ras?
    Lee, Jung-Won
    van Wijnen, Andre
    Bae, Suk-Chul
    RUNX PROTEINS IN DEVELOPMENT AND CANCER, 2017, 962 : 321 - 332
  • [25] P27 tumor suppressor protein regulates Ras activity
    Hoffmann, Rachel
    Moeller, Stephanie J.
    Kennedy, Steven
    LePage, Daniel
    Sheaff, Robert J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [26] Characterization of a novel oncogenic K-ras mutation in colon cancer
    Akagi, Kiwamu
    Uchibori, Ryosuke
    Yamaguchi, Kensei
    Kurosawa, Keiko
    Tanaka, Yoichiro
    Kozu, Tomoko
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 352 (03) : 728 - 732
  • [27] Selenoprotein W regulates tumor suppressor p53 in prostate epithelial cells
    Hawkes, Wayne Chris
    Printsev, Ignat
    Alkan, Zeynep
    FASEB JOURNAL, 2010, 24
  • [28] Tumor suppressor p53 transcriptionally regulates Bak expression in pancreatic cancer
    Bowles, Tawnya L.
    Mortenson, Melinda M.
    Galante, Joseph M.
    Schlieman, Michael G.
    Virudachalam, Subbulakshmi
    Bold, Richard J.
    CANCER RESEARCH, 2006, 66 (08)
  • [29] A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice
    Y Wang
    Z Zhang
    R A Lubet
    M You
    Oncogene, 2006, 25 : 1277 - 1280
  • [30] A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice
    Wang, Y
    Zhang, Z
    Lubet, RA
    You, M
    ONCOGENE, 2006, 25 (08) : 1277 - 1280
12345